
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
HIVers considering switching from a protease inhibitor to an NNRTI should talk with their doctors about an alarming possibility: a relapse of Kaposi's sarcoma. A report in the Journal of Acquired Immune Deficiency Syndromes has shown that 17.6% of HIVers with a previous case of KS experienced a relapse when switching from a PI to an NNRTI. The researchers say the relapses may be due to the 'anti-angiogenic, anti-KS, and antitumor effects' associated with PIs that are diminished when other anti-HIV drugs are taken.
From our Sponsors
Most Popular
Plus: Featured Video